Study of the Safety and Efficacy of Prenofitol Tablets

A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 160 participants.

Also called NCT07908433

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 160 participants (planned count) (from the registry)
Sponsor
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation (from the registry)
Registry
  • NCT NCT07908433
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07908433. Randomized; quadruple masking; primary purpose prevention. Start 2026-11-02 (anticipated); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of the Safety and Efficacy of Prenofitol Tablets
Condition
Dyslipidemia
Intervention (Drug)
1 tablet of Prenofitol
Intervention (Drug)
2 tablets of Prenofitol
Intervention (Drug)
1 tablet of placebo
Intervention (Drug)
2 tablets of placebo
Lead sponsor
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation (class: other)

Record details

Record id
cardio:ct-nct07908433
Content hash
10ec68a3a652042a68e77b0edb3f647dd583f11fb22d43b50e824ff265ca712d